[go: up one dir, main page]

PT1328268E - Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica - Google Patents

Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica

Info

Publication number
PT1328268E
PT1328268E PT01988587T PT01988587T PT1328268E PT 1328268 E PT1328268 E PT 1328268E PT 01988587 T PT01988587 T PT 01988587T PT 01988587 T PT01988587 T PT 01988587T PT 1328268 E PT1328268 E PT 1328268E
Authority
PT
Portugal
Prior art keywords
pharmaceutical
combination
quercetine
catheter
catechin
Prior art date
Application number
PT01988587T
Other languages
English (en)
Inventor
Trimboli Domenico
Gatti Valter
Naccari Gian Carlo
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Publication of PT1328268E publication Critical patent/PT1328268E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
PT01988587T 2000-10-25 2001-10-11 Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica PT1328268E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI002312A IT1320080B1 (it) 2000-10-25 2000-10-25 Composizione per uso farmaceutico o dietetico.

Publications (1)

Publication Number Publication Date
PT1328268E true PT1328268E (pt) 2005-08-31

Family

ID=11446037

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01988587T PT1328268E (pt) 2000-10-25 2001-10-11 Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica

Country Status (12)

Country Link
US (1) US7956040B2 (pt)
EP (1) EP1328268B1 (pt)
JP (1) JP2004512304A (pt)
AT (1) ATE291424T1 (pt)
AU (2) AU2061702A (pt)
CA (1) CA2425933C (pt)
DE (1) DE60109632T2 (pt)
ES (1) ES2238495T3 (pt)
IT (1) IT1320080B1 (pt)
NZ (1) NZ525339A (pt)
PT (1) PT1328268E (pt)
WO (1) WO2002034262A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011416A (es) 2002-05-17 2005-09-30 Othera Pharmaceuticals Inc Mejora del desarrollo de las cataratas y otras enfermedades oftalmicas.
AU2007229399B2 (en) * 2002-06-21 2010-12-23 L'oreal Use of taurine or derivatives thereof for the treatment of alopecia
JP5041664B2 (ja) 2002-06-21 2012-10-03 ロレアル 脱毛症を治療するためのタウリンの利用
US7825134B2 (en) 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
WO2005055926A2 (en) * 2003-11-20 2005-06-23 Othera Pharmaceuticals, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
EP1706107A1 (en) * 2004-01-07 2006-10-04 Unilever Plc Synergistic neuroprotective combinations of flavanols, hydroxystilbenes, flavanones, flavones, flavonols, proanthocyanidins and anthocyanidins
DE102004041270A1 (de) * 2004-08-26 2006-03-02 Merz Pharma Gmbh & Co. Kgaa Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung
JP2006083105A (ja) * 2004-09-16 2006-03-30 Ito En Ltd 血液流動性改善剤および飲食物
WO2006076681A2 (en) * 2005-01-13 2006-07-20 Sirtris Pharmaceuticals, Inc. Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
WO2006079021A2 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
CN101374535A (zh) * 2005-12-23 2009-02-25 玛尔斯有限公司 皮肤保护及改善
GB0819960D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic composition
IT1393841B1 (it) 2009-04-30 2012-05-11 Giuliani Spa Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
IT1401289B1 (it) 2010-04-22 2013-07-18 Giuliani Spa Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
US20120183587A1 (en) * 2011-01-18 2012-07-19 Mitsunori Ono Flavonol compositions
ES2391211B1 (es) * 2011-05-04 2013-10-02 Select Botanical, S.L. Combinacion sinergica de polifenoles
FR2981272A1 (fr) * 2011-10-14 2013-04-19 Inneov Lab Utilisation d'une composition orale comprenant un melange d'au moins un polyphenol, de zinc, et de vitamine c.
JP5769611B2 (ja) * 2011-12-08 2015-08-26 株式会社ピカソ美化学研究所 育毛剤組成物
EP2925160B1 (en) 2012-11-29 2018-03-14 Nestec S.A. Increasing the bioavailability of flavan-3-ols by polyphenols
ITMI20130397A1 (it) * 2013-03-15 2014-09-16 Giuliani Spa Composizione a base di flavonidi per uso farmaceutico, nutrizionale o cosmetico con potenziata azione antiossidante
WO2017122668A1 (ja) 2016-01-12 2017-07-20 国立大学法人 東京医科歯科大学 脱毛および白毛化を抑制もしくは改善するための組成物ならびにその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5244375B2 (pt) * 1974-04-19 1977-11-08
JP3480953B2 (ja) * 1992-08-17 2003-12-22 株式会社コーセー 皮膚外用剤
JP3480956B2 (ja) * 1992-10-16 2003-12-22 株式会社コーセー 皮膚外用剤
US6569446B1 (en) * 1996-09-20 2003-05-27 The Howard Foundation Solubilization of flavonols
DE69841217D1 (de) 1997-01-13 2009-11-19 Univ Emory Glutathion zur behandlung von influenzainfektionen
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
DE60014931D1 (de) * 1999-08-20 2004-11-18 Howard Murad Pharmazeutische zusammensetzungen und verfahren zur verminderung des cellulite auftretens

Also Published As

Publication number Publication date
IT1320080B1 (it) 2003-11-18
US7956040B2 (en) 2011-06-07
DE60109632T2 (de) 2006-02-09
JP2004512304A (ja) 2004-04-22
EP1328268B1 (en) 2005-03-23
ATE291424T1 (de) 2005-04-15
ES2238495T3 (es) 2005-09-01
US20040014686A1 (en) 2004-01-22
WO2002034262A1 (en) 2002-05-02
DE60109632D1 (de) 2005-04-28
NZ525339A (en) 2004-10-29
AU2061702A (en) 2002-05-06
ITMI20002312A1 (it) 2002-04-25
CA2425933C (en) 2011-05-03
AU2002220617B2 (en) 2005-04-28
EP1328268A1 (en) 2003-07-23
CA2425933A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
PT1328268E (pt) Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica
TR200003735T2 (tr) Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2002081651A3 (en) Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
WO2003018059A3 (de) Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung
EP2772254A3 (en) Novel Antibacterial Agents
ATE500747T1 (de) Zusammensetzung zur erhöhung der leistungsfähigkeit des körpers
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
BRPI0508117A (pt) composições de bebida ácida
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
FR2842103B1 (fr) Nouvelles applications cosmetiques de polyphenoles et de leurs derives
DK1139980T3 (da) Kosmetisk eller medicinsk praparat til topisk anvendelse
TNSN03043A1 (en) 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
TR200103151T2 (tr) Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon.
ZA200502464B (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome.
WO2008058717A3 (de) Kosmetische zubereitungen mit hohem glyceringehalt
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
WO2002089740A3 (en) Sulfonamides
WO2002032445A3 (de) Hemmung der interaktion zwischen oxidierte proteine und cd36 oder dessen wirkmechanismus
HUP0303462A3 (en) Synergetic antimicrobial compositions, preparation and use thereof
MXPA04001230A (es) Uso de inhibidores de il-18 en desordenes de hipersensibilidad.
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression